Abstract | INTRODUCTION:
Intravitreal injections are a very common procedure and are the most effective route of drug delivery to the retina. There are currently several drugs available and even more are in development; therefore, safety is a very important concern. AREAS COVERED: EXPERT OPINION:
|
Authors | Fernando M Penha, Eduardo B Rodrigues, Bruno A Furlani, Eduardo Dib, Gustavo B Melo, Michel E Farah |
Journal | Expert opinion on drug metabolism & toxicology
(Expert Opin Drug Metab Toxicol)
Vol. 7
Issue 8
Pg. 1021-34
(Aug 2011)
ISSN: 1744-7607 [Electronic] England |
PMID | 21627546
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Anti-Bacterial Agents
- Antibodies, Monoclonal, Humanized
- Vascular Endothelial Growth Factor A
- Triamcinolone
- Bevacizumab
- Ranibizumab
|
Topics |
- Animals
- Anti-Bacterial Agents
(therapeutic use)
- Antibodies, Monoclonal, Humanized
(toxicity)
- Bevacizumab
- Clinical Trials as Topic
- Humans
- Intravitreal Injections
(adverse effects, methods)
- Macular Degeneration
(drug therapy)
- Macular Edema
(drug therapy)
- Ranibizumab
- Triamcinolone
(toxicity)
- Vascular Endothelial Growth Factor A
(antagonists & inhibitors)
|